What is Alliance Pharma?
Founded in 1996 and headquartered in the United Kingdom, Alliance Pharma operates as a pharmaceutical company focused on the acquisition, marketing, and sales of pharmaceutical and consumer healthcare products. The company has built a robust portfolio through strategic acquisitions, positioning itself as a key player in its market segments. Its business model emphasizes the lifecycle management of established products, ensuring continued market access and revenue generation.
How much funding has Alliance Pharma raised?
Alliance Pharma has raised a total of $190.4M across 1 funding round:
Debt
$190.4M
Debt (2015): $190.4M with participation from Silicon Valley Bank
Key Investors in Alliance Pharma
Silicon Valley Bank
Silicon Valley Bank, established in 1983, is a financial institution providing a comprehensive suite of banking and financial services. It specializes in supporting technology and life science companies, offering commercial banking, asset management, and investment services.
What's next for Alliance Pharma?
The recent major strategic investment signals a new phase of expansion for Alliance Pharma. This capital infusion is likely to fuel further product acquisitions, market penetration efforts, and potentially research and development into new healthcare solutions. The company's established track record and strategic focus suggest a trajectory aimed at consolidating its market position and exploring new avenues for growth within the dynamic pharmaceutical landscape.
See full Alliance Pharma company page
